Morgan Stanley Upgrades Manhattan Associates to Overweight from Equal-Weight
Fintel reports that on October 12, 2026, Morgan Stanley upgraded their outlook for Manhattan Associates (NASDAQGS:MANH) (BMV:MANH) from Equal-Weight to Overweight. This rating action on October 12, 2026, follows a prior action by Morgan Stanley on January 5, 2026, when the firm maintained its rating of Equal-Weight.
Manhattan Associates, Inc., based in the United States, is a prominent player in the supply chain and omnichannel commerce technology sector. The company specializes in providing advanced software solutions that facilitate efficient supply chain management for a diverse range of industries, including retail, manufacturing, and logistics. Key projects typically involve the implementation of their Manhattan Active® suite, which integrates capabilities such as enterprise management, store fulfillment, and inventory planning. This suite is designed to help businesses optimize their operations, increase efficiency, and enhance customer satisfaction by enabling seamless commerce solutions.
On October 12, 2026, the company's latest close was recorded at $218.03. This represents a price change of +6.12% over one week, compared to a baseline close of $205.45 on October 5, 2026. Over a one-month period, the stock experienced a price change of +8.03% from a baseline close of $201.82 on September 11, 2026. Prior to the rating action, the stock closed at $204.89 on October 9, 2026.
The company's latest earnings report was released on July 28, 2026. For that period, Manhattan Associates reported actual earnings per share (EPS) of 1.39, exceeding the estimated EPS of 1.3441, which represents an EPS surprise percent of +3.41%. Actual revenue for the quarter was $297,794,000.00, compared to the estimated revenue of $293,672,616.00. The company's upcoming earnings date is scheduled for October 27, 2026.
Separately, on September 28, 2026, DA Davidson downgraded Manhattan Associates from Buy to Neutral. As of October 2, 2026, the current consensus target mean for the stock was $221.67, and the current consensus target median was $219.30, representing an implied change percent of +1.67%. This is a revision from the prior consensus target mean of $218.89 recorded on September 15, 2026, which is a consensus target revision percent of +1.27%.
For the current recommendation period of September 1, 2026, the aggregate recommendations consisted of 7 strong buy, 9 buy, and 3 hold ratings, totaling 19 recommendations. This represents 84.2% positive recommendations and 15.8% hold recommendations. In the prior recommendation period of August 1, 2026, the total recommendations were also 19, consisting of 6 strong buy, 10 buy, and 3 hold ratings, which also represented 84.2% positive recommendations and 15.8% hold recommendations.
Recent analyst actions
| Date | Analyst | Prior | Latest recommendation | Action |
|---|---|---|---|---|
| October 12, 2026 | Morgan Stanley | Equal-Weight | Overweight | upgrade |
| September 28, 2026 | DA Davidson | Buy | Neutral | downgrade |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.